Home›Stock Screener›Desh Rakshak Aushdhalaya

Desh Rakshak Aushdhalaya Share Price Today | Stock Price & Desh Rakshak Aushdhalaya Share Screener

DESHRAK Pharmaceuticals & Biotechnology

Track the current Desh Rakshak Aushdhalaya share price and stock price live with TickJournal's free stock screener. Track Desh Rakshak Aushdhalaya marketcap in USD to gauge the company's total market size. Use the Desh Rakshak Aushdhalaya stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Desh Rakshak Aushdhalaya opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹7 and net income of ₹1, with EBITDA of ₹1, an operating margin of 22.0% and a profit margin of 14.3%.

Desh Rakshak Aushdhalaya Market Cap ₹13.40 Cr.
DESHRAK P/E Ratio (TTM) 24.20
Desh Rakshak Aushdhalaya P/B Ratio 1.03
EPS (TTM) ₹0.99
Dividend Yield -
Debt to Equity 0.25
DESHRAK 52 Week High -
Desh Rakshak Aushdhalaya 52 Week Low -
Operating Margin 22.00%
Profit Margin 14.29%
DESHRAK Revenue (TTM) ₹7.00
EBITDA ₹1.00
Net Income ₹1.00
Total Assets ₹21.00
Total Equity ₹13.00

Desh Rakshak Aushdhalaya Share Price Chart

Track the current stock price of Desh Rakshak Aushdhalaya with an interactive chart. Analyse DESHRAK share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Desh Rakshak Aushdhalaya stock quote in one place.

Desh Rakshak Aushdhalaya Company Profile - Fundamental Screener

Screen Desh Rakshak Aushdhalaya company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for DESHRAK shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals & Biotechnology industry, and it trades under ISIN INE971E01016.

Company Details

Classification

Sector Healthcare
Industry Pharmaceuticals & Biotechnology
Sub-Sector Pharmaceuticals & Biotechnology
Segment E

Identifiers and Leadership

ISIN INE971E01016

Desh Rakshak Aushdhalaya Balance Sheet Screener

Screen DESHRAK balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹21, up from ₹18 in 2025.

Latest statistics put total assets at ₹21 and shareholder funds at ₹13, with a leverage ratio of 0.25.

Item 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017

Assets

Total Assets 21 18 16 16 16 15 12 11 11 10
Current Assets 0 0 0 0 0 0 0 0 0 0
Fixed Assets 8 8 8 8 8 7 5 4 4 4

Liabilities

Total Liabilities 0 0 0 0 0 0 0 0 0 0
Current Liabilities 3 3 3 4 4 3 2 1 1 1
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 13 10 10 9 9 9 8 8 8 7
Share Capital 6 5 5 5 5 5 5 5 5 5
Reserves & Surplus 7 5 5 5 5 4 4 3 3 3

Desh Rakshak Aushdhalaya Income Statement Screener - Profit & Revenue Analysis

Screen Desh Rakshak Aushdhalaya income statement and profit fundamentals. Analyze DESHRAK quarterly results. Desh Rakshak Aushdhalaya reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For None-None, revenue was ₹7 and net profit was ₹1, equal to earnings per unit of ₹1.10, at an operating margin of 22%.

In that period expenses were ₹6, interest cost ₹0 and tax ₹0. The next period listed, 2026-March, shows revenue of ₹7 and net profit of ₹1.

Item None-None 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March 2016-March 2015-March

Revenue and Expenses

Revenue 7 7 6 6 6 6 7 5 6 5 5 5 5
Expenses 6 6 5 5 5 5 6 4 5 4 4 4 4

Operating Costs and Margins

EBITDA 1 1 1 1 1 1 1 1 1 1 1 1 1
Operating Profit % 22.00% 20.00% 20.00% 21.00% 21.00% 19.00% 14.00% 15.00% 14.00% 14.00% 13.00% 14.00% 14.00%
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0 1
Interest 0 0 0 0 0 0 0 0 0 0 0 0 0

Profit and Earnings

Profit Before Tax 1 1 1 1 1 1 1 0 0 0 0 0 0
Tax 0 0 0 0 0 0 0 0 0 0 0 0 0
Net Profit 1 1 1 0 0 1 0 0 0 0 0 0 0
EPS 1.10 0.99 1.07 0.96 0.91 1.08 0.95 0.69 0.76 0.64 0.63 0.00 0.05

Desh Rakshak Aushdhalaya Cash Flow Screener - Liquidity Fundamentals

Screen DESHRAK cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities used ₹1.

Over the same period, investing activities used ₹2 and financing activities provided ₹3.

Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March

Cash from Operations and Investing

Operating Activities -1 0 2 0 0 1 1 -1 0 0
Investing Activities -2 0 0 -1 -2 -1 -1 0 0 -1

Financing and Net Cash

Financing Activities 3 0 -1 0 1 1 1 0 0 0
Net Cash Flow 0 0 0 0 0 0 0 0 0 -1

Desh Rakshak Aushdhalaya Shareholding Pattern Screener

See Desh Rakshak Aushdhalaya shareholding pattern with promoter, FII, and DII holdings. Check Desh Rakshak Aushdhalaya promoter holding and ownership changes for DESHRAK on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Sept, promoters held 50.03%, foreign institutions 0.00%, domestic institutions 0.00% and the public 49.84%, spread across 2,392 shareholders.

The shareholder count was 2,392 in 2026-Sept, compared with 2,391 in 2026-Jun.

Item 2026-Sept 2026-Jun 2026-Mar 2025-Dec 2025-Sept 2025-Jun 2025-Mar 2024-Dec

Promoter Holding

Promoter Holding 50.03% 50.03% 50.03% 50.03% 50.07% 50.07% 64.28% 64.28%

Institutional Investors

FII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 49.84% 49.84% 49.83% 49.84% 49.84% 49.84% 35.64% 35.65%
Other Holding 0.14% 0.14% 0.14% 0.14% 0.09% 0.09% 0.07% 0.06%
Shareholder Count 2,392 2,391 2,393 2,411 2,429 2,428 2,353 2,345

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Desh Rakshak Aushdhalaya. Desh Rakshak Aushdhalaya dividend yield can be compared with peers and other stocks in the market.

No dividends declared by Desh Rakshak Aushdhalaya.

Desh Rakshak Aushdhalaya Stock Index Membership - Nifty & Sensex

See which indices include Desh Rakshak Aushdhalaya stock. Check DESHRAK index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

Desh Rakshak Aushdhalaya is not part of any tracked indices.
Only major market indices are tracked in our system.

Desh Rakshak Aushdhalaya Market Events Screener - Corporate Actions

Get Desh Rakshak Aushdhalaya corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Desh Rakshak Aushdhalaya stock events that may affect DESHRAK share price, along with derivatives, futures and options activity and sector gainers.

14 corporate actions are listed, the most recent entry being Annual General Meeting dated December 30, 2026, with a record date of December 30, 2026.

It is followed by Quarterly Result Announcement dated November 14, 2026 and Annual General Meeting dated September 25, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-12-30 2026-12-30 Annual General Meeting NA -9.09%
2026-11-14 2026-11-14 Quarterly Result Announcement NA -4.08%
2026-09-25 2026-09-25 Annual General Meeting NA 0.00%
2026-08-13 2026-08-13 Quarterly Result Announcement NA -3.74%
2026-05-29 2026-05-29 Quarterly Result Announcement NA 15.74%
2026-02-13 2026-02-13 Quarterly Result Announcement NA -9.52%
2025-12-06 2025-12-06 Quarterly Result Announcement NA -4.86%
2025-11-14 2025-11-14 Quarterly Result Announcement NA 4.75%
2025-08-13 2025-08-13 Quarterly Result Announcement NA -3.95%
2025-05-30 2025-05-30 Quarterly Result Announcement NA -1.99%
2025-05-29 2025-05-29 Extraordinary General Meeting NA 12.83%
2025-02-13 2025-02-13 Quarterly Result Announcement NA 27.53%
2024-11-14 2024-11-14 Quarterly Result Announcement NA 0.00%
2024-09-30 2024-09-30 Annual General Meeting NA 0.00%

Desh Rakshak Aushdhalaya Competitors Screener - Peer Stocks Comparison

Screen DESHRAK competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 448,076 41.10 61,674 12.69% 11,565 59.98
Divis Laboratories 294,139 90.70 11,067 13.95% 2,568 67.88
Torrent Pharmaceuticals 178,438 84.50 13,886 20.34% 2,138 49.31
Laurus Labs 119,949 98.10 6,868 22.01% 890 49.19
Zydus Life Science 118,902 27.60 27,658 17.64% 5,026 52.87
Dr Reddys Laboratories 115,011 41.70 35,059 3.90% 4,158 69.34
Cipla 112,656 39.40 29,045 2.24% 3,870 55.82
Mankind Pharma 108,490 48.40 14,636 14.85% 1,938 63.62
Aurobindo Pharma 103,223 26.40 34,145 5.56% 3,503 60.38
Lupin 90,393 17.30 29,039 26.75% 5,356 44.23

Desh Rakshak Aushdhalaya Company Announcements - News & Reports Screener

Screen DESHRAK latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated November 19, 2026.

The next most recent announcements are dated November 19, 2026 and November 19, 2026.

Date Update Actions
2026-11-19 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-11-19 Non-Applicability Of Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 For The Half Year Ended 30Th September 2026 -
2026-11-19 Non-Applicability Of Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 For The Half Year Ended 30Th September 2026 -
2026-11-18 Statement Of No Deviation(S) Or Variation(S) In The Use Of Proceeds Under Regulation 32 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations). -
2026-11-18 Statement Of No Deviation(S) Or Variation(S) Under Regulation 32 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 -
2026-11-18 Intimation Pursuant To Regulation 30 Of The Securities And Exchange Board Of India (SEBI) (Listing Obligations And Disclosure Requirements) Regulations 2015 -
2026-11-18 Submission Of Unaudited Financial Results For The Quarter And Half Year Ended 30Th September 2026 As Per Regulation 33 Of The Securities And Exchange Board Of India (SEBI) (Listing Obligations And Disclosure Requirements) Regulations 2015 -
2026-11-18 Board Meeting Outcome for Outcome Of Board Meeting Pursuant To Para A Of Part A Of Schedule III And Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 -
2026-11-15 Board Meeting Intimation for Pre Intimation Of The Board Meeting As Per Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. -
2026-10-14 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-10-14 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-09-27 Closure of Trading Window -
2026-09-26 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2026-09-25 Intimation Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 -
2026-09-25 Announcement under Regulation 30 (LODR)-Change in Directorate -
2026-09-25 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2026-09-02 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-09-02 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-09-01 Disclosure Under Regulation 30 Of The Securities And Exchange Board Of India (SEBI) (Listing Obligations And Disclosure Requirements) Regulations 2015 -
2026-08-27 Intimation Regarding Book Closure -

Frequently Asked Questions

How is the company valued right now?

The P/E ratio is 24.20 and the P/B ratio is 1.03, with earnings per unit of ₹0.99. Market capitalisation stands at ₹13.40 Cr. The company operates in the Healthcare sector, in the Pharmaceuticals & Biotechnology industry, so compare these ratios with its sector peers in the table above.

About This Data

Key statistics were last updated on November 20, 2026. This page covers 10 balance sheet periods, 13 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.